NCT02439684

Brief Summary

This is a cross-sectional study that aims to assess the sensitivity and specificity of using HbA1c as a diagnostic test for detecting the presence of diabetes mellitus (DM) when compared to the use of oral glucose tolerance test (OGTT) among Hong Kong Chinese adult who have impaired fasting glucose (IFG). The investigators will recruit around 1000 non-diabetic adult participants who have impaired fasting glucose (i.e. fasting glucose level between 5.6 to 6.9mmol/L) AND without symptoms of hyperglycaemia to undergo both HbA1c test and oral glucose tolerance test after obtaining their informed consent. A diagnosis of DM is confirmed when both the fasting glucose level and 2-hour-post challenge plasma glucose level fall into diabetic range (i.e. fasting glucose level ≥7.0mmol/L and 2-hour-post challenge plasma glucose level ≥11.1mmol/L) after a standard 75g OGTT. Participants with only 1 plasma glucose value within the diabetic range will be invited to repeat an oral glucose tolerance test for confirmation of their diagnosis as recommended by American Diabetes Association and World Health Organization. Demographic data of the participants including age, gender, smoking status, medical history, diet and activity level will be collected. Lipid profile, blood pressure, waist circumference and body mass index will be checked and the total cardiovascular risk in 10 years will be calculated for each participant using the Joint British Societies 2005 and Framingham 2008 equations to evaluate the baseline cardiovascular risk of the participants. These data will be analyzed using SPSS. The primary outcomes are the sensitivity and specificity of HbA1c in detecting diabetes mellitus diagnosed by oral glucose tolerance test (the gold standard). A receiver operating characteristic (ROC) curve will be obtained by plotting sensitivity against (1-specificity) for each cutoff value for identification of an optimal cutoff point. Diagnostic accuracy will be assessed by the area under the curve (AUC). The differences in characteristics among participants diagnosed to have diabetes mellitus by oral glucose tolerance test or HbA1c will be compared using independent t-test or χ2 test for comparison between the 2 groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,357

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2013

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2015

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 12, 2015

Completed
Last Updated

March 7, 2016

Status Verified

March 1, 2016

Enrollment Period

1.8 years

First QC Date

April 23, 2015

Last Update Submit

March 4, 2016

Conditions

Keywords

HbA1cDiagnostic accuracyDiabetes MellitusChineseImpaired fasting glucose

Outcome Measures

Primary Outcomes (2)

  • The sensitivity of the use of HbA1c

    The sensitivity of the use of HbA1c at different cut points for diagnosing DM among Chinese adult patients with IFG compared to OGTT as the gold standard.

    around 12-16 weeks after the study completed

  • The specificity of the use of HbA1c

    The specificity of the use of HbA1c at different cut points for diagnosing DM among Chinese adult patients with IFG compared to OGTT as the gold standard.

    around 12-16 weeks after the study completed

Secondary Outcomes (5)

  • The optimal cut-off level of HbA1c

    around 12-16 weeks after the study completed

  • OGTT criteria in Chinese

    around 12-16 weeks after the study completed

  • HbA1c criteria in Chinese

    around 12-16 weeks after the study completed

  • Cardiovascular risk

    around 24-48 weeks after the study completed

  • DM risk

    around 24-48 weeks after the study completed

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chinese adult subjects who are classified to have IFG will be recruited from various GOPCs from the Hong Kong West Cluster and New Territories East Cluster.

You may qualify if:

  • Aged ≥ 18 year
  • Chinese ethnicity
  • Diagnosis of impaired fasting glucose (i.e. FG between 5.6-6.9mmol/L) identified from latest blood test results within 18 months prior to recruitment)

You may not qualify if:

  • Known history of diabetes mellitus or on hypoglycaemic treatment
  • Having symptoms of hyperglycaemia at recruitment
  • Women who are pregnant or breast-feeding at recruitment
  • Patients taking glucocorticoid at recruitment
  • Active and uncontrolled thyroid diseases (including subjects on thyroid replacement therapy or anti-thyroid drugs) or active endocrine diseases such as Cushing's syndrome or Acromegaly at recruitment
  • Clinically significant anaemia at recruitment
  • Severe renal impairment i.e. eGFR ≤ 30 ml/min/1.73m2
  • History of blood donation or blood transfusion within 3 months prior to recruitment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Tsan Yuk Hospital RAMP Clinic

Hong Kong, 852, Hong Kong

Location

Ap Lei Chau General Out-patient Clinic

Hong Kong, Hong Kong

Location

Lek Yuen General Out-patient Clinic

Hong Kong, Hong Kong

Location

Related Publications (2)

  • Guo VY, Yu EY, Wong CKh, Sit RW, Wang JH, Ho SY, Lam CL. Validation of a nomogram for predicting regression from impaired fasting glucose to normoglycaemia to facilitate clinical decision making. Fam Pract. 2016 Aug;33(4):401-7. doi: 10.1093/fampra/cmw031. Epub 2016 May 3.

  • Yu EY, Wong CK, Ho SY, Wong SY, Lam CL. Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose? Fam Pract. 2015 Dec;32(6):631-8. doi: 10.1093/fampra/cmv077. Epub 2015 Oct 14.

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • YU YT Esther, Doctor

    Department of Family Medicine and Primary Care, The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2015

First Posted

May 12, 2015

Study Start

May 1, 2013

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

March 7, 2016

Record last verified: 2016-03

Locations